New therapy aspects for myeloid chronic lymphoma

New line of therapy for acute myeloid leukaemia

Avoiding radiotherapy is an option for some older patients with breast cancer

New agents in CLL

Chronic lymphocytic leukaemia: A new treatment era is born

Final stage II results of the CLL11 trial

Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation

Elderly population needs new definition to inform treatment decisions

Expert care is needed for elderly haematology patients

Variations in terminal sedation practices across the UK, Netherlands and Belgium

The future of CLL treatment: balancing efficacy, safety and cost

Making sense of the expanding armoury of treatment options for the less fit CLL patient